Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

Neurology

Volumn 54, Issue 7, 2000, Pages 1498-1504

  Kahle, P J ^a   Jakowec, M ^b   Teipel, S J ^c   Hampel, H ^c   Petzinger, G M ^b   Di Monte, D A ^b   Silverberg, G D ^a   Moller H J ^c   Yesavage, J A ^a   Tinklenberg, J R ^a   Shooter, E M ^a   Murphy Jr , Greer M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PARKINSON S INSTITUTE   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

AD CSF; AD7C NTP; Tau

Indexed keywords

NERVE PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0034636147     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.7.1498     Document Type: Article

References (28)

1. Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology 1995;45:211-218.
2. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
3. Forno L. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-272.
4. Growdon JH. Consensus report of the Working Group on "Molecular and Biochemical Markers of Alzheimer's Disease". Neurobiol Aging 1998;19:109-116.
5. Iqbal K, Alonso AC, Gong CX, et al. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm 1998;53(suppl):169-180.
6. Vandermeeren M, Mercken M, Vanmechelen E, et al. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993;61:1828-1834.
7. Vigo-Pelfrey C, Seubert P, Barbour R, et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 1995;45:788-793.
8. Hock C, Golombowski S, Naser W, Müller-Spahn F. Increased levels of β protein in cerebrospinal fluid of patients with Alzheimer's disease-correlation with degree of cognitive impairment. Ann Neurol 1995;37:414-415.
9. Kanai M, Matsubara E, Isoe K, et al. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol 1998;44:17-26.
10. Arai H, Terajima M, Miura M, et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 1995;38:649-652.
11. Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ∈4 during 14 months follow-up. Neurosci Lett 1996;214:163-166.
12. Tapiola T, Lehtovirta M, Ramberg J, et al. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology 1998;50:169-74.
13. Andreasen N, Vanmechelen E, Van de Voorde A, et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry 1998;64:298-305.
14. Arai H, Morikawa Y, Higuchi M, et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun 1997;236:262-264.
15. de la Monte SM, Ghanbari K, Frey WH, et al. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. J Clin Invest 1997;100:3093-3104.
16. de la Monte SM, Carlson RI, Brown NV, Wands JR. Profiles of neuronal thread protein expression in Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:1038-1050.
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
20. Langsten JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
21. Ghanbari K, Ghanbari HA. A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test. J Clin Lab Anal 1998;12:223-226.
22. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995;38:643-648.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839-843.
24. Hampel H, Teipel SJ, Padberg F, et al. Discriminant power of combined CSF tau and soluble gp130 in the diagnosis of Alzheimer's disease. Brain Res 1999;823:104-112.
25. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
26. Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 1998;8:299-324.
27. Tapiola T, Overmyer M, Lehtovirta M, et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. NeuroReport 1997;8:3961-3963.
28. Isoe K, Urakami K, Shimomura T, et al. Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study. Dementia 1996;7:175-176. Letter.